Page 392 - Biomedical Engineering and Design Handbook Volume 1, Fundamentals
P. 392

BIOCERAMICS  369

              15.3.4 Critical Properties of Bioactive Ceramics
                          Important needs in bioactive ceramics research and development include characterization of the
                          processing-composition-structure-property synergy, characterization of in vivo function, and estab-
                          lishing predictive relationships between in vitro and in vivo outcomes. Understanding reactions at
                          the ceramic surface and improving the ceramic/tissue bond depend on (Ducheyne, 1987) (1) charac-
                          terization of surface activity, including surface analysis, biochemistry, and ion transport; (2) physical
                          chemistry, pertaining to strength and degradation, stability of the tissue/ceramic interface and tissue
                          resorption; and (3) biomechanics, as related to strength, stiffness, design, wear, and tissue remodeling.
                          These properties are time dependent and should be characterized as functions of loading and envi-
                          ronmental history.
                            Physical/chemical properties that are important to characterize and relate to biological response
                          include powder particle size and shape, pore size, shape and distribution, specific surface area,
                          phases present, crystal structure and size, grain size, density, coating thickness, hardness, and surface
                          roughness.
                            Starting powders may be identified for their particle size, shape, and distribution, via sifting tech-
                          niques or quantitative stereology. Pore size, shape, and distribution, important properties with respect
                          to strength and bioreactivity, may be quantified via stereology and/or SEM. Specific surface area,
                          important in understanding the dissolution and precipitation reactions at the ceramic/fluid interface,
                          may be characterized by B.E.T. Phase identification may be accomplished via XRD and FTIR. Grain
                          sizes may be determined through optical microscopy, SEM, or TEM. Auger electron spectroscopy
                          (AES) and x-ray photoelectron spectroscopy (XPS) may also be utilized to determine surface and
                          interfacial compositions. Chemical stability and surface activity may be analyzed via XPS and mea-
                          surements of ionic fluxes and zeta potentials.
                            An additional factor that should be considered in evaluating chemical stability and surface activity
                          of bioceramics is the aqueous microenvironment and how closely it simulates the in vivo environ-
                          ment. The type and concentration of electrolytes in solution and the presence of proteins or cells may
                          influence how the ceramic surface changes when it interacts with a solution. For example, a solution
                          with constituents, concentrations, and pH equivalent to human plasma most accurately reproduces
                          surface changes observed in vivo, whereas more standard buffers do not reproduce these changes
                          (Kokubo et al., 1990b).
                            The integrity of a biomaterial/tissue interface is dependent on both the implant and tissue.
                          Therefore, both of these constituents should be well characterized: the implant surface should be
                          analyzed and the species released into the environment and tissues should also be determined.
                          Surface analyses can be accomplished with solution chemical methods, such as atomic absorption
                          spectroscopy; physical methods, such as thin film XRD, electron microprobe analysis (EMP), energy
                          dispersive x-ray analysis (EDXA), FTIR, and surface-sensitive methods, such as AES, XPS, and sec-
                          ondary ions mass spectroscopy (SIMS) (Fig. 15.6). The integrity of an implant/tissue interface also
                          depends on the loading pattern, since loading may alter the chemical and mechanical behavior of the
                          interface.
                            The major factors limiting expanded use of bioactive ceramics are their low-tensile strength and
                          fracture toughness. The use of bioactive ceramics in bulk form is therefore limited to functions in
                          which only compressive loads are applied. Approaches that may allow ceramics to be used in sites
                          subjected to tensile stresses include (1) use of the bioactive ceramic as a coating on a metal or ceramic
                          substrate (Ducheyne et al., 1980), (2) strengthening the ceramic, such as via crystallization of glass
                          (Gross et al., 1981), (3) use fracture mechanics as a design approach (Ritter et al., 1979), and
                          (4) reinforcing the ceramic with a second phase (Ioku et al., 1990; Kitsugi et al., 1986; Knowles and
                          Bonfield, 1993; Li et al., 1995).
                            No matter which of these strategies is used, the ceramic must be stable, both chemically and
                          mechanically, until it fulfills its intended function(s). The property requirements depend upon the
                          application. For example, if a metallic total hip prosthesis is to be fixed to bone by coating the stem
                          with a Ca-P coating, then the ceramic/metal bond must remain intact throughout the service life of
                          the prosthesis. However, if the coating will be used on a porous coated prosthesis with the intent of
                          accelerating ingrowth into the pores of the metal, then the ceramic/metal bond need only be stable
                          until tissue ingrowth is achieved. In either scenario, mechanical testing of the ceramic/metal bond,
   387   388   389   390   391   392   393   394   395   396   397